Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1996-12-17
2000-01-04
Jones, Dwayne C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514649, A01N 3302
Patent
active
060110694
ABSTRACT:
There is disclosed a multidrug resistance inhibitor for overcoming a multidrug resistance of cancer, or an agent for enhancing the activity of anti-cancer agents, which comprises as an active ingredient a compound of formula (I) or a pharmaceutically acceptable salt thereof: ##STR1## wherein n is an integer of 5 to 12,
REFERENCES:
patent: 4645862 (1987-02-01), Tahara et al.
patent: 4658063 (1987-04-01), Tahara et al.
patent: 4700002 (1987-10-01), Tahara et al.
patent: 4723008 (1988-02-01), Tahara et al.
Patent Abstracts of Japan, vol. 11, No. 30, (C-400), Jan. 29, 1987, JP 61 200913, Sep. 5, 1986.
Journal National Cancer Institute, vol. 76, No. 5, pp. 947-953, May 1986, Teruhito Yamaguchi, et al., "Overcoming Drug Resistance in Cancer Cells with Synthetic Isoprenoids".
Takashi Tsuruo, et al. "Overcoming of Vincristine Resistance in P388 Leukemia in Vivo and in Vitro through Enhanced Cytotoxicity of Vincristine and Vinblastine by Verapamil", Cancer Research, vol. 41, (pp. 1967-1972), May 1981.
Carol O. Cardarelli, et al. "Differential Effects of P-Glycoprotein Inhibitors on NIH3T3 Cells Transfected with Wild-Type (G185) or Mutant (V185) Multidrug Transporters", Cancer Research, vol. 55, (pp. 1086-1091), Mar. 1, 1995.
Ikemoto Hiroyuki
Inomata Kohei
Inoue Hitoshi
Kawamura Kouji
Kishiye Takao
Jones Dwayne C.
Nisshin Flour Milling Co. Ltd.
LandOfFree
Multidrug resistance inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multidrug resistance inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multidrug resistance inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1073067